Recommended videos you might also like
06:58
VAM 2023: Dr. R. Clement Darling and Dr. Manuel Perez-Izquierdo Discussion
![](https://reachora-public-videos.imgix.net/v/101/c/3/694b2f-f1b5-4502-bd97-a4cab4a13212/thumbnails/image_1.jpg)
10:50
Our Experience with Barostim in over 40 Patients to Date
![](https://reachora-public-thumbnails.imgix.net/uploaded/production/bfddbbf7-fda4-4ba8-b533-af05a55496f8.jpg)
12:13
HRS2023 Symposium Discussion US Commercial Heart Failure
![](https://reachora-public-thumbnails.imgix.net/uploaded/production/3516fcd4-9061-47ed-8ba8-93c1460498d5.jpg)
11:45
What's next for Baroreflex Activation Therapy?
![](https://reachora-public-thumbnails.imgix.net/uploaded/production/932ad55a-e740-477e-896b-de5db301d0cb.jpg)
14:35
Barostim in the EP's HFrEF Toolbox
![](https://reachora-public-thumbnails.imgix.net/uploaded/production/ee9f295f-f06e-4675-b214-595da787e7d5.jpg)
11:23
Device Options for HFrEF
![](https://reachora-public-thumbnails.imgix.net/uploaded/production/70be0e88-5b84-4143-862a-8fddd24fa7c8.jpg)
Unmet Needs and Device Therapies in HFrEF
5 views
Barostim™ Baroreflex Activation Therapy is a new option for patients with heart failure that utilizes the carotid baroreflex to target autonomic imbalance in the cardiovascular system.
Join the conversation
to comment